Counterfeit pharmaceuticals threaten the most vulnerable populations and undermine Africa’s ability to achieve UN sustainable development goals (SDGs), a report has warned.
Greater prioritisation of the problem of counterfeit medicines in Africa by policymakers at continental, national and regional level may help prevent widespread loss of life, as well as mitigating other public health and safety risks, the report said.